A detailed history of New England Research & Management, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, New England Research & Management, Inc. holds 1,650 shares of ELV stock, worth $662,458. This represents 0.4% of its overall portfolio holdings.

Number of Shares
1,650
Previous 1,700 2.94%
Holding current value
$662,458
Previous $921,000 6.84%
% of portfolio
0.4%
Previous 0.44%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$500.12 - $562.29 $25,006 - $28,114
-50 Reduced 2.94%
1,650 $858,000
Q2 2024

Jul 09, 2024

SELL
$497.49 - $547.8 $161,684 - $178,034
-325 Reduced 16.05%
1,700 $921,000
Q1 2024

Apr 16, 2024

BUY
$464.61 - $519.96 $58,076 - $64,995
125 Added 6.58%
2,025 $1.05 Million
Q4 2023

Feb 06, 2024

SELL
$433.51 - $488.06 $15,172 - $17,082
-35 Reduced 1.81%
1,900 $896,000
Q3 2023

Oct 10, 2023

SELL
$414.13 - $475.93 $492,814 - $566,356
-1,190 Reduced 38.08%
1,935 $843,000
Q2 2023

Jul 05, 2023

SELL
$436.33 - $496.2 $159,260 - $181,113
-365 Reduced 10.46%
3,125 $1.39 Million
Q1 2023

Apr 06, 2023

SELL
$446.3 - $502.2 $316,873 - $356,562
-710 Reduced 16.9%
3,490 $1.61 Million
Q4 2022

Jan 09, 2023

SELL
$465.23 - $546.77 $576,885 - $677,994
-1,240 Reduced 22.79%
4,200 $2.15 Million
Q3 2022

Oct 06, 2022

BUY
$445.98 - $507.0 $412,531 - $468,975
925 Added 20.49%
5,440 $2.47 Million
Q2 2022

Jul 20, 2022

BUY
$444.32 - $529.84 $566,508 - $675,546
1,275 Added 39.35%
4,515 $2.18 Million
Q2 2021

Jul 15, 2021

SELL
$352.19 - $401.9 $422,628 - $482,280
-1,200 Reduced 27.03%
3,240 $1.24 Million
Q1 2021

Apr 16, 2021

BUY
$287.7 - $371.31 $1.28 Million - $1.65 Million
4,440 New
4,440 $1.59 Million

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $96.4B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.